Supply-chain explainer
UK peptide manufacturing explained: who actually makes the molecules
Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)
Last updated 2026-05-21
If you are researching UK research-peptide retailers, the question that decides trust is whether the vial in the box originated at a named, regulated facility, or at an unnamed one. The PeptideClear CoA Trust Index uses that distinction as its central signal. This page explains what "named lab" actually means in the UK context: who the real UK peptide manufacturers are, how peptides get made, and why a retailer that can name its synthesis source is operating on different ground from one that cannot.
The three Tier 1 UK manufacturers profiled here (Almac, Sterling, Biosynth Pepceuticals) supply pharmaceutical-grade Active Pharmaceutical Ingredients (APIs) to global pharma and biotech. None of them sells to consumers. None of them ships research vials. The point of naming them is to give you a reference for what "real" UK peptide manufacturing looks like, so that the named-lab disclosure on a retailer page becomes legible rather than abstract.
How peptide manufacturing actually works in the UK
Almost all commercial peptides shorter than around 70 amino acids are made by solid-phase peptide synthesis (SPPS), the Merrifield method first published in 1963. Amino acids are added one at a time to a chain anchored on an insoluble resin, with wash and deprotection cycles between additions. Final cleavage releases the chain. HPLC purification removes truncated sequences and side-products. Mass spectrometry confirms identity.
Pharmaceutical-grade peptide manufacturing in the UK happens under the same regulatory regime as any other Active Pharmaceutical Ingredient: it is overseen by the Medicines and Healthcare products Regulatory Agency (MHRA), conducted under Good Manufacturing Practice (GMP), and the facilities are periodically inspected. A facility holding a Manufacturer's Authorisation for Investigational Medicinal Products (MIA(IMP)) can supply clinical-trial material. Multi-kilogram commercial supply requires further demonstrated capability. Most UK CDMOs (Contract Development and Manufacturing Organisations) operate at both research and GMP grades, with the GMP arm sitting under documented MHRA inspection cycles.
Research-grade peptide synthesis (for academic labs, biotech R&D, in vitro work) sits outside that pharmaceutical regulatory perimeter but uses the same chemistry. Several UK labs publish ISO 9001 quality systems and ISO/IEC 17025 testing accreditation as the research-grade quality floor. Neither tier touches a consumer market: pharma-grade material goes into prescription medicines, research-grade goes into laboratories. The grey-market research-peptide retailer space is downstream of both, and the supply chain back into named UK synthesis is rarely disclosed.
The three named UK peptide manufacturers we reference
These are the UK facilities whose published credentials, scale, and customer base are clearest. They are the reference points PeptideClear uses when the CoA Trust Index measures whether a retailer's synthesis source is verifiable.
Almac Group · Craigavon, Northern Ireland
Almac Group is a global CDMO with heritage dating to 1968 (operating as Almac Group since 2002) and Northern Ireland headquarters in Craigavon. Almac Sciences, the chemical development and API arm, opened an expanded 28,000 square foot GMP peptide facility in 2024, capable of producing peptides longer than 70 amino acids including vaccine peptide cocktails. Almac is MHRA-inspected and serves more than 600 pharma and biotech customers. Publicly disclosed product launches Almac has supported include Agios Pharmaceuticals' Pyrukynd (mitapivat, approved for pyruvate kinase deficiency), Sanofi's Tzield (teplizumab, the first disease-modifying therapy for type 1 diabetes), and PTC Therapeutics' Upstaza (eladocagene exuparvovec, a gene therapy for AADC deficiency). When pharmaceutical companies need a named UK peptide manufacturer to put on regulatory submissions, Almac is one of the names that appears.
Sterling Pharma Solutions · Cramlington, Northumberland
Sterling Pharma Solutions is a UK-headquartered CDMO at Dudley Lane, Cramlington, with six facilities and more than 1,350 staff. Sterling's peptide capability covers more than 25 years of synthesis experience with chain lengths up to 40 amino acids, full SPPS, downstream purification, and analytical method development. The company trademarked the term PDMO (Pharmaceutical Development and Manufacturing Organisation) in 2020 to differentiate its end-to-end small-molecule, ADC, and peptide service. Sterling is MHRA-regulated and operates at clinical and commercial scale. Its named-customer roster is not publicly itemised (typical for CDMOs supplying branded pharma) but the scale, the Northumberland headquarters, the 50-year operating history, and the published 40-amino-acid peptide capability are the credibility hooks.
Biosynth Pepceuticals · Leicester, England
Pepceuticals Ltd is the UK GMP peptide arm of Biosynth, acquired in September 2023. The Leicestershire facility (Enderby, Feldspar Close) covers 10,000 square feet across eight cGMP laboratories. Pepceuticals is an MHRA-approved API manufacturer holding MIA(IMP) certification, supporting multi-kilogram GMP peptide synthesis from early clinical trials through to commercial supply. A £2 million facility investment expanded capacity post-acquisition. Biosynth also operates Cambridge Research Biochemicals in Billingham, Teesside (acquired May 2023), which handles complex peptide chemistry, fluorescent labelling, and antibody tools at the research grade. For UK readers, Pepceuticals is the most geographically placeable of the three: an East Midlands GMP peptide facility, MHRA-inspected, currently shipping commercial-grade peptide APIs.
Smaller named UK peptide labs
Three more UK labs sit one rung down in scale but contribute to the picture of a real UK peptide synthesis industry. AltaBioscience (37 Walkers Road, Redditch, B98 9HE, Companies House 07278564) is a 1973-founded peptide and amino-acid-analysis lab, originally a University of Birmingham spin-out, now UKAS-accredited under ISO 9001:2015 and ISO/IEC 17025:2017 for testing. It serves pharma, academia, biotech, contract manufacturers, and the food industry.
Isca Biochemicals (26 Hanover Road, Exeter, EX1 2TL, incorporated October 2012) is the spin-out of the former Biomol peptide manufacturing arm. It runs custom synthesis alongside a publicly visible research-grade catalogue covering antimicrobial peptides, neuropeptides, FRET substrates, and kinase reagents. The combination of a named address, 13-year incorporation, and an open catalogue gives it stronger named-lab credibility than most grey-market retailers.
Cambridge Research Biochemicals (Billingham, Teesside), the Biosynth research-grade UK subsidiary, handles complex peptide chemistry, fluorescent labelling, and antibody conjugation. Mentioned alongside its sister facility Pepceuticals when the UK Biosynth footprint is the topic, although Pepceuticals (Leicester) is the GMP headline.
UK peptide-adjacent suppliers we do not include
Two UK companies came up in supplier research that we deliberately exclude from named-lab editorial because the framing would mislead a reader. Activotec (Cambridge) is primarily a peptide-synthesizer hardware vendor: it sells the machines (Activo-Darwin, Activo-P11) that other labs use to perform SPPS. It does run a small custom synthesis service, but characterising it as a UK peptide manufacturer would conflate equipment vendor with manufacturer.
Isomerase Therapeutics (Chesterford Research Park, Cambridge, Companies House 08335008) is a recombinant peptide and synthetic-biology service: it produces peptides via engineered microbes (cell-free and cell-based bioprocesses) rather than by chemical SPPS. It is a credible UK company but is solving a different problem in a different chemistry, and naming it alongside SPPS CDMOs would confuse the supply-chain picture readers come here to clarify.
What this means when you read a Certificate of Analysis
The named-lab signal on a UK research peptide retailer page is rarely "manufactured at Almac". Almac, Sterling, and Pepceuticals supply branded pharma APIs, not unbranded research vials. The named-lab signal that actually matters at the consumer end is whether the third-party testing laboratory on the Certificate of Analysis can be verified, and whether per-batch CoAs are published rather than a one-off CoA image being reused.
What the existence of named UK manufacturers does tell you is what the regulated baseline looks like. MHRA inspection. GMP facilities. Manufacturer's authorisations under documented numbers. Multi-kilogram audited batches. If a retailer cannot name where its peptides are synthesised, that gap is the gap: real UK peptide manufacturing is named, regulated, and inspected, and consumer-facing retailers that originate downstream of that regime should be able to describe their own supply chain in comparable detail.
Related reading: CoA Trust Index · UK research peptide retailers compared · Solid-phase peptide synthesis (SPPS) explained · Certificate of Analysis explained · HPLC purity.
Research-use-only framing. PeptideClear is an editorial comparison and information service. The UK manufacturers named on this page do not sell to consumers and have no commercial relationship with PeptideClear. Editorial commentary based on publicly available information at the time of review. Last reviewed 2026-05-21.